136 related articles for article (PubMed ID: 10159788)
1. Price, value, and chaos theory in strategic management.
Coss TA
J Cardiovasc Manag; 1996; 7(4):21-4. PubMed ID: 10159788
[No Abstract] [Full Text] [Related]
2. Role of technology assessment in health benefits coverage for medical devices.
Braslow NM; Shatin D; McCarthy DB; Newcomer LN
Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
[TBL] [Abstract][Full Text] [Related]
3. Improving end-of-life care.
Beresford L
Healthplan; 1999; 40(2):25-6, 28-30. PubMed ID: 10537468
[No Abstract] [Full Text] [Related]
4. Coping with cost constraints.
Vienken J
Med Device Technol; 1997 Nov; 8(9):37. PubMed ID: 10174629
[No Abstract] [Full Text] [Related]
5. Industry economics in the United States.
Med Device Technol; 2004 Apr; 15(3):34-6. PubMed ID: 15255538
[TBL] [Abstract][Full Text] [Related]
6. Measuring DM's net effect is harder than you might think.
Johnson A
Manag Care; 2003 Jun; 12(6):28-32. PubMed ID: 12854257
[No Abstract] [Full Text] [Related]
7. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
8. The need for greater price transparency in the medical device industry: an economic analysis.
Hahn RW; Klovers KB; Singer HJ
Health Aff (Millwood); 2008; 27(6):1554-9. PubMed ID: 18997211
[TBL] [Abstract][Full Text] [Related]
9. Germany health-care systems at the turning point.
Schmitt JM
Med Device Technol; 2001 Oct; 12(8):35-6. PubMed ID: 12938549
[TBL] [Abstract][Full Text] [Related]
10. Difficult decisions: weighing treatment costs and benefits.
Wainio JA
Hosp Technol Ser; 1995 Jan; 14(1):1-3. PubMed ID: 10140805
[No Abstract] [Full Text] [Related]
11. Medical technology at the crossroads.
Bailey PG
Adm Radiol; 1987 Nov; 6(11):40-3. PubMed ID: 10312356
[No Abstract] [Full Text] [Related]
12. Drug and health outcomes measurement in clinical practice.
Ibern P
Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():45-6. PubMed ID: 9800730
[No Abstract] [Full Text] [Related]
13. Managing managed care--controlling our destiny.
Halamandaris VJ
Caring; 1996 Jan; 15(1):4, 7-9, 39. PubMed ID: 10154908
[No Abstract] [Full Text] [Related]
14. Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment.
Sheehan DV; Wright-Etter PJ
Manag Care Q; 2002; 10(3):21-31. PubMed ID: 12476662
[TBL] [Abstract][Full Text] [Related]
15. Reducing technology costs and risks in a managed care environment.
Halverson K
Manag Care Q; 1997; 5(1):30-2. PubMed ID: 10164647
[TBL] [Abstract][Full Text] [Related]
16. Purchasers and the impact of managed care on physicians.
Coulter CH
Physician Exec; 1998; 24(1):30-8. PubMed ID: 10180485
[TBL] [Abstract][Full Text] [Related]
17. Chaos theory.
Straub K
Health Manag Technol; 1997 Sep; 18(10):12-5. PubMed ID: 10170215
[No Abstract] [Full Text] [Related]
18. The limited state of technology assessment for medical devices: facing the issues.
Ramsey SD; Luce BR; Deyo R; Franklin G
Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
[TBL] [Abstract][Full Text] [Related]
19. Is a paradigm shift in US healthcare reimbursement inevitable?
Watanabe AM; Dollens RW; Malatestinic WN; Browne RA
Circulation; 2004 Mar; 109(12):1456-9. PubMed ID: 15051649
[No Abstract] [Full Text] [Related]
20. Managed health care: outcomes and update.
Wenzel RP
Curr Clin Top Infect Dis; 1999; 19():216-25. PubMed ID: 10472488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
